Company profile
ImmunoShield Therapeutics
Building bridges from cells to cures
- Industry
- Biotechnology Research
- Employees
- 3
- Headquarters
- Phoenix, Arizona
- Founded
- 2021
- LinkedIn followers
- 106
- Office locations
- 1
ImmunoShield Therapeutics company summary
ImmunoShield Therapeutics is a company in the Biotechnology Research industry, headquartered in Phoenix, Arizona, founded in 2021. On LinkedIn the company has around 3 employees and 106 followers. Its listed specialties include Biomanufacturing, Biomaterials, Cell Encapsulation, Regenerative Medicine.
What technology does ImmunoShield Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ImmunoShield Therapeutics
ImmunoShield Therapeutics seeks to deliver allogeneic, tissue specific cell therapies in safer, more scalable, and accessible formats without chronic systemic immunosuppression. Our dual-technology approach combines high-throughput macroencapsulation of cells with a drug-free approach to address cell graft rejection after implantation, enabling pharmaceutical partners to deliver allogeneic cell products to broader patient populations with reduced immunosuppression risk. Initially targeting type 1 diabetes in partnership with cell therapy developers, ImmunoShield Therapeutics aims to transform chronic disease treatment from lifelong management to functional cure.
Specialties
Where is ImmunoShield Therapeutics located?
ImmunoShield Therapeutics lists 1 location.
Compare companies similar to ImmunoShield Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ImmunoShield Therapeutics immunoshieldtherapeutics.com | Biotechnology Research | 3 | 2021 | Phoenix, Arizona |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ImmunoShield Therapeutics
What does ImmunoShield Therapeutics do?
ImmunoShield Therapeutics seeks to deliver allogeneic, tissue specific cell therapies in safer, more scalable, and accessible formats without chronic systemic immunosuppression. Our dual-technology approach combines high-throughput macroencapsulation of cells with a drug-free approach to address cell graft rejection after implantation, enabling pharmaceutical partners to deliver allogeneic cell products to broader patient populations with reduced immunosuppression risk. Initially targeting type 1 diabetes in partnership with cell therapy developers, ImmunoShield Therapeutics aims to transform chronic disease treatment from lifelong management to functional cure.
How many employees does ImmunoShield Therapeutics have?
ImmunoShield Therapeutics has around 3 employees on LinkedIn.
Where is ImmunoShield Therapeutics headquartered?
ImmunoShield Therapeutics is headquartered in Phoenix, Arizona.
When was ImmunoShield Therapeutics founded?
ImmunoShield Therapeutics was founded in 2021.
Build a lead list from companies like ImmunoShield Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.